Transgender and Gender Nonbinary Individuals' Assigned Female at Birth Experiences and Preferences With Gendered Advertisement and Packaging of Contraception [ID 2683586

Abstract

INTRODUCTION: Transgender and gender nonbinary individuals assigned female at birth (TGNB-AFAB) use contraceptives for a variety of reasons including menstrual suppression or pregnancy prevention. However, the use of contraceptives could trigger gender dysphoria and deter use. Our goal is to determine the effect of gendered advertisement on the use of contraceptives in this population. METHODS: TGNB-AFAB individuals, ages 18 and older, participated in an online anonymous survey about their experiences with sexual and reproductive health care. The study was IRB approved by Emory University. RESULTS: Ninety-two TGNB-AFAB individuals responded. The mean age was 34 (SD 7.8). The majority of respondents identified as White (89.3%) and non-Hispanic (94.0%). 66 (78.6%) were college educated. 33 (38.4%) respondents currently use contraception. Primary forms of contraception include oral contraceptives (15.6%), condoms (21.9%), intrauterine devices, and implants (21.9%). 38 (45.2%) reported gendered advertisement or packaging makes them less likely to use contraceptives and 62 (73.8%) believed gendered advertisement makes other TGNB-AFAB individuals less likely to use contraceptives. 36 (42.9%) respondents said they would be more likely to use contraceptives if the packaging were gender neutral or gender inclusive and 33 (39.3%) if it was marketed specifically for trangender and gender-diverse individuals. The data from this study are preliminary. CONCLUSION: Contraceptive use is common in TGNB-AFAB; however, gendered advertising and packaging can be a deterrent for these individuals. Gender-neutral and/or gender-inclusive advertisement could potentially increase the use of contraceptives in this population.